AND MISCONCEPTIONS IN THE MANAGEMENT OF SEPSIS

Size: px
Start display at page:

Download "AND MISCONCEPTIONS IN THE MANAGEMENT OF SEPSIS"

Transcription

1 MYTHS AND MISCONCEPTIONS IN THE MANAGEMENT OF SEPSIS SEPSISMADE EASY SURVIVINGSEPSIS COOKBOOK SEPSIS ISAPIE MERVYN SINGER BLOOMSBURY INSTITUTE OF INTENSIVE CARE MEDICINE UNIVERSITY COLLEGE LONDON, UK

2 DISCUSSION POINTS.. Guidelines should be slavishly followed One size fits all Every hour of antibiotic delay kills How long should a course of antibiotics last? Sepsis mortality is improving Why do people die of sepsis?

3 DISCUSSION POINTS.. Guidelines should be slavishly followed One size fits all Every hour of antibiotic delay kills How long should a course of antibiotics last? Sepsis mortality is improving Why do people die of sepsis?

4 INDIVIDUALS VERSUS POPULATION

5 INDIVIDUALS VERSUS POPULATION Patients do NOT necessarily follow the rule book MUST tailor therapy to the individual Guidelines should NOT be used as rigid protocols/rules of stone Clinical expertise is VITAL

6 INDIVIDUALS VERSUS POPULATION Patients do NOT necessarily follow the rule book MUST tailor therapy to the individual Guidelines should NOT be used as rigid protocols/rules of stone Clinical expertise is VITAL.. not my words, but David Sackett s

7

8

9 QUALITY - OR LACK - OF EVIDENC

10 QUALITY - OR LACK - OF EVIDENC Overall evidence base for sepsis is - sadly - rather weak Only a few awarded high quality (but generally do nots rather than do s )

11 DOGMA SHOULDN T RULE Need decent evidence to confirm need to change For example, Rivers showed EGDT was beneficial in but why?

12 DOGMA SHOULDN T RULE Need decent evidence to confirm need to change For example, Rivers showed EGDT was beneficial in but why?

13 DOGMA SHOULDN T RULE Need decent evidence to confirm need to change For example, Rivers showed EGDT was beneficial in but why?

14 DOGMA SHOULDN T RULE Need decent evidence to confirm need to change For example, Rivers showed EGDT was beneficial in but why?

15 DOGMA SHOULDN T RULE Need decent evidence to confirm need to change For example, Rivers showed EGDT was beneficial in but why?

16

17

18

19 TAKE-HOME MESSAGE Identify patient early Treat promptly and appropriately.. but the specific Rivers protocol doesn t seem to offer any overall added benefit

20 LOWEST COMMON DENOMINATOR? good performing hospitals not-so-good performing hospitals Standardised mortality ratio

21 LOWEST COMMON DENOMINATOR? good performing hospitals Standardised mortality ratio? rigid protocol application not-so-good performing hospitals

22 LOWEST COMMON DENOMINATOR? good performing hospitals Standardised mortality ratio? rigid protocol application? rigid protocol application not-so-good performing hospitals

23 LOWEST COMMON DENOMINATOR? good performing hospitals Standardised mortality ratio? rigid protocol application? rigid protocol application not-so-good performing hospitals

24 BUT. Guidelines are often taken too literally by: clinical zealots institutions governments

25 BUT. Guidelines are often taken too literally by: clinical zealots institutions governments.. with financial penalties or name-and-shame for non-compliance

26 TAKE-HOME MESSAGE Use guidelines/protocols as an aide memoire.. but not rules of stone Don t be afraid to deviate.. but be able to justify why

27 DISCUSSION POINTS.. Guidelines should be slavishly followed One size fits all Every hour of antibiotic delay kills How long should a course of antibiotics last? Sepsis mortality is improving Why do people die of sepsis?

28 THE INTERVENTION.. OR TARGETED ENDPOIN.. MUST BE RATIONAL FOR EVERYONE

29

30

31

32

33 S O W H Y TA R G E T A P O P U L AT I O N, AND NOT AN INDIVIDUAL!!!!!

34

35

36

37

38 TAKE-HOME MESSAGE

39 TAKE-HOME MESSAGE Titrate to the individual e.g. what BP suits them? MAP or 75-80?

40 TAKE-HOME MESSAGE Titrate to the individual e.g. what BP suits them? MAP or 75-80? Titrate to a goal if a patient needs fluid (if hypovolaemia -> hypoperfusion), give fluid if not hypovolaemic and hypoperfused, don t give fluid

41 TAKE-HOME MESSAGE Titrate to the individual e.g. what BP suits them? MAP or 75-80? Titrate to a goal if a patient needs fluid (if hypovolaemia -> hypoperfusion), give fluid if not hypovolaemic and hypoperfused, don t give fluid Avoid excess - too much fluid, too much oxygen, too much catecholamine

42 DISCUSSION POINTS.. Guidelines should be slavishly followed One size fits all Every hour of antibiotic delay kills How long should a course of antibiotics last? Sepsis mortality is improving Why do people die of sepsis?

43 INTERESTING FACTS - 1

44 INTERESTING FACTS - 1 Multiple papers - including EVERY prospective study I m aware of do NOT show a correlation between a short-term delay in administering antibiotics and mortality

45 INTERESTING FACTS - 2

46 INTERESTING FACTS - 2 Studies claiming every hour counts are all based on retrospective analyses of databases collected for other reasons (usually administrative), but lacking vital data e.g. antibiotic sensitivities

47 INTERESTING FACTS - 2 Studies claiming every hour counts are all based on retrospective analyses of databases collected for other reasons (usually administrative), but lacking vital data e.g. antibiotic sensitivities.. and use complex adjustments to find a mortality difference

48 INTERESTING FACTS - 2 Studies claiming every hour counts are all based on retrospective analyses of databases collected for other reasons (usually administrative), but lacking vital data e.g. antibiotic sensitivities.. and use complex adjustments to find a mortality difference.. and often incorporate very delayed treatment (>6h) into the analysis

49 INTERESTING FACTS - 2 Studies claiming every hour counts are all based on retrospective analyses of databases collected for other reasons (usually administrative), but lacking vital data e.g. antibiotic sensitivities.. and use complex adjustments to find a mortality difference.. and often incorporate very delayed treatment (>6h) into the analysis.. and often lack biological plausibility

50 INTERESTING FACTS - 2 Studies claiming every hour counts are all based on retrospective analyses of databases collected for other reasons (usually administrative), but lacking vital data e.g. antibiotic sensitivities.. and use complex adjustments to find a mortality difference.. and often incorporate very delayed treatment (>6h) into the analysis.. and often lack biological plausibility.. and cannot explain why there was a delay in treatment in some

51 Survival time following hypotension (hours)

52 Survival 7.6% decrease in survival per hour of delay time following hypotension (hours)

53 Survival 7.6% decrease in survival per hour of delay time following hypotension (hours)

54 Survival time following hypotension (hours)

55 Survival time following hypotension (hours)

56 Survival time following hypotension (hours)

57 Survival time following hypotension (hours)

58 Survival time following hypotension (hours)

59 Survival time following hypotension (hours)

60 Survival n=2154 time following hypotension (hours)

61 Survival n=2154 time following hypotension (hours)

62 Survival n=558 n=2154 time following hypotension (hours)

63

64

65

66

67 ED Ward ICU Mortality (%) Time to antibiotic (hr) >6

68 ED Ward ICU Mortality (%) Time to antibiotic (hr) >6

69 ED Ward ICU Mortality (%) Time to antibiotic (hr) >6

70 ED Ward ICU Mortality (%) Time to antibiotic (hr) >6

71 ED Ward ICU Mortality (%) Time to antibiotic (hr) >6

72 ED Ward ICU Mortality (%) Time to antibiotic (hr) >6

73

74 1373 ICU patients between coded as septic/septic shock

75 1373 ICU patients between coded as septic/septic shock

76 1373 ICU patients between coded as septic/septic shock

77 1373 ICU patients between coded as septic/septic shock

78

79

80

81

82

83

84

85

86

87

88

89

90 and no data on antibiotic sensitivities, adequacy of dosing, source control, etc..

91

92 .. yet 45% of patients (early and late treated) had septic shock!!

93

94

95 82.5% of pts 2% of pts

96 23.6% 22.6% 82.5% of pts 2% of pts

97 82.5% of pts 15.5% of pts 2% of pts

98 82.5% of pts 15.5% of pts 2% of pts

99 82.5% of pts 15.5% of pts 2% of pts

100 82.5% of pts 15.5% of pts 2% of pts

101 PROSPECTIVE STUDIES SHOW NO DIFFERENC

102 PROSPECTIVE STUDIES SHOW NO DIFFERENC Often designed to specifically look at impact of antibiotics on outcomes None show an each-hour-delay-kills signal Puskarich, CCM 2011 septic shock (ED) Hranjec, Lancet Infect Dis 2012 sepsis/septic shock (ICU) Kaasch, Infection 2013 S aureus bacteraemia (Ward/ICU) Bloos, Crit Care 2014 sepsis/septic shock (ICU) De Groot, Crit Care 2015 ED sepsis/septic shock (ED) Fitzpatrick, Clin Microbiol Infect 2016 Gm -tive bacteraemia (Ward) Alan, Lancet Respir Dis 2018 sepsis (pre-hospital ED)

103 prospective observational study in 3 Dutch EDs hospitalized ED patients requiring iv antibiotics stratified by illness severity (low, intermediate, high) time to antibiotics <1 hour vs 1-3 hours v >3 hours 1168 patients enrolled - overall mortality 10% 85% received antibiotics within 3 hours, 95% within 6 hours

104 No association between time to a/b and surviving days outside hospital or mortality In low illness severity group, delayed (>3h) antibiotics associated with more surviving days outside hospital (HR 1.46 (95%CI )

105

106 2672 patients randomised to receive pre-hospital antibiotics (ceftriaxone 2g) from paramedics on suspicion of sepsis OR start antibiotics in ED Mean 96 minute difference in time to administration of antibiotics

107

108

109

110

111

112 TAKE-HOME MESSAGE

113 TAKE-HOME MESSAGE Every second doesn t count.. but reasonable/rational to treat sepsis and septic shock promptly Rather than simply throwing antibiotics at the patient, apply some thought, seek advice, and think source control

114 DISCUSSION POINTS.. Guidelines should be slavishly followed One size fits all Every hour of antibiotic delay kills How long should a course of antibiotics last? Sepsis mortality is improving Why do people die of sepsis?

115

116

117

118

119

120

121

122

123

124 6 month audit in University hospital medical-surgical ICU

125 6 month audit in University hospital medical-surgical ICU 113 bacteraemia episodes in 87 patients

126 6 month audit in University hospital medical-surgical ICU 113 bacteraemia episodes in 87 patients Short-course monotherapy (4-5 days) used in 65.7%

127 6 month audit in University hospital medical-surgical ICU 113 bacteraemia episodes in 87 patients Short-course monotherapy (4-5 days) used in 65.7% Low rates of bacteraemia breakthrough/relapse

128 6 month audit in University hospital medical-surgical ICU 113 bacteraemia episodes in 87 patients Short-course monotherapy (4-5 days) used in 65.7% Low rates of bacteraemia breakthrough/relapse Very low incidence of antimicrobial resistance or fungaemia

129 6 month audit in University hospital medical-surgical ICU 113 bacteraemia episodes in 87 patients Short-course monotherapy (4-5 days) used in 65.7% Low rates of bacteraemia breakthrough/relapse Very low incidence of antimicrobial resistance or fungaemia Less ICU-acquired MRSA, MDR Gram -tives, VRE and fluconazole-resistant candidaemia c/f similar audit in 2000

130

131

132

133 fluconazole-resistant

134 fluconazole-resistant methicillin -resistant

135 fluconazole-resistant methicillin -resistant VRE

136 fluconazole-resistant methicillin -resistant VRE MDR

137 fluconazole-resistant methicillin -resistant VRE MDR no fluconazole-resistance

138 fluconazole-resistant methicillin -resistant VRE MDR 1 VRE no fluconazole-resistance

139 fluconazole-resistant methicillin -resistant VRE MDR no MRSA 1 VRE no fluconazole-resistance

140 fluconazole-resistant methicillin -resistant VRE no MRSA 1 VRE no MDR MDR no fluconazole-resistance

141

142

143 4 vs 8 days

144 DISCUSSION POINTS.. Guidelines should be slavishly followed One size fits all Every hour of antibiotic delay kills How long should a course of antibiotics last? Sepsis mortality is improving Why do people die of sepsis?

145

146

147

148

149 781, ,270

150 781, , , ,124

151 781, , , ,124

152 781,725??? under-reported 118,676??? over-reported 300, ,124

153

154

155

156

157

158 DISCUSSION POINTS.. Guidelines should be slavishly followed One size fits all Every hour of antibiotic delay kills How long should a course of antibiotics last? Sepsis mortality is improving Why do people die of sepsis?

159

160

161

162 MAINTAINING A SENSE OF PROPORTION

163 MAINTAINING A SENSE OF PROPORTION 34 million antibiotic prescriptions by English GPs in

164 MAINTAINING A SENSE OF PROPORTION 34 million antibiotic prescriptions by English GPs in million hospital patient episodes with a sepsis/infection code in England p.a.

165 MAINTAINING A SENSE OF PROPORTION 34 million antibiotic prescriptions by English GPs in million hospital patient episodes with a sepsis/infection code in England p.a... with 32,300 in-hospital deaths = 2.5% mortality rate

166 MAINTAINING A SENSE OF PROPORTION 34 million antibiotic prescriptions by English GPs in million hospital patient episodes with a sepsis/infection code in England p.a... with 32,300 in-hospital deaths = 2.5% mortality rate BUT only 11,000 cases of sepsis had an ICU admission

167 DO ALL SEPTIC PATIENTS WARRANT LIFE-PROLONGING TREATMENT???

168 DO ALL SEPTIC PATIENTS WARRANT LIFE-PROLONGING TREATMENT??? Pneumonia is the old man s friend - Sir William Osler Patients may be allowed to die from sepsis due to the severity of their underlying comorbidity - terminal cancer, severe stroke, end-stage chronic organ failure, severe dementia

169 N SUSPICIONOF SEPSIS HOSPITALADMISSIONS IN ENGLAND Age

170 SUSPICIONOF SEPSIS HOSPITALADMISSIONS IN ENGLAND N Age SUSPICIONOF SEPSIS MORTALITY Mortality (%) Age 90+

171 SUSPICIONOF SEPSIS HOSPITALADMISSIONS IN ENGLAND N Age SUSPICIONOF SEPSIS MORTALITY Mortality (%) 77.5% OF DEATHS Age 90+

172 SUSPICIONOF SEPSIS HOSPITALADMISSIONS IN ENGLAND N Age 20 8% OF DEATHS SUSPICIONOF SEPSIS MORTALITY Mortality (%) 77.5% OF DEATHS Age 90+

173

174

175 Dementia? Stroke? Other severe disability?

176 Dementia? Stroke? Other severe disability?

177 CONCLUSION

178 CONCLUSION Apply physiology to patient management

179 CONCLUSION Apply physiology to patient management Personalization not rigid protocolization

180 CONCLUSION Apply physiology to patient management Personalization not rigid protocolization Challenge dogma based on weak/contrived evidence

181 CONCLUSION Apply physiology to patient management Personalization not rigid protocolization Challenge dogma based on weak/contrived evidence Sepsis only constitutes a small proportion of infection but should be identified and acted upon promptly.. but with some thought applied

182 CONCLUSION Apply physiology to patient management Personalization not rigid protocolization Challenge dogma based on weak/contrived evidence Sepsis only constitutes a small proportion of infection but should be identified and acted upon promptly.. but with some thought applied

ESISTONO LE HCAP? Francesco Blasi. Sezione Medicina Respiratoria Dipartimento Toraco Polmonare e Cardiocircolatorio Università degli Studi di Milano

ESISTONO LE HCAP? Francesco Blasi. Sezione Medicina Respiratoria Dipartimento Toraco Polmonare e Cardiocircolatorio Università degli Studi di Milano ESISTONO LE HCAP? Francesco Blasi Sezione Medicina Respiratoria Dipartimento Toraco Polmonare e Cardiocircolatorio Università degli Studi di Milano Community-acquired pneumonia (CAP): Management issues

More information

DOES TIMING OF ANTIBIOTICS IMPACT OUTCOME IN SEPSIS? Saravana Kumar MD HEAD,DEPT OF EM,DR MEHTA S HOSPITALS CHENNAI,INDIA

DOES TIMING OF ANTIBIOTICS IMPACT OUTCOME IN SEPSIS? Saravana Kumar MD HEAD,DEPT OF EM,DR MEHTA S HOSPITALS CHENNAI,INDIA DOES TIMING OF ANTIBIOTICS IMPACT OUTCOME IN SEPSIS? Saravana Kumar MD HEAD,DEPT OF EM,DR MEHTA S HOSPITALS CHENNAI,INDIA drsaravanakumar.ep@gmail.com JOINT SECRETARY RECOMMENDATIONS: INITIAL RESUSCITATION

More information

Early Antibiotics for Sepsis and Septic Shock: A Gold Standard

Early Antibiotics for Sepsis and Septic Shock: A Gold Standard Early Antibiotics for Sepsis and Septic Shock: A Gold Standard Anand Kumar MD, FRCPC, FCCP, FCCM Professor of Medicine University of Manitoba Health Sciences Centre St. Boniface Hospital Winnipeg, Manitoba

More information

Sepsis. ...striking a balance. Dr Ron Daniels.

Sepsis. ...striking a balance. Dr Ron Daniels. Sepsis...striking a balance Dr Ron Daniels Fellow: NHS Improvement Faculty Chair: United Kingdom Sepsis Group, Sepsis Trust & UK SSC Sepsis as a Global Emergency Committee, Global Sepsis Alliance Midland

More information

Antimicrobial Resistance Update for Community Health Services

Antimicrobial Resistance Update for Community Health Services Antimicrobial Resistance Update for Community Health Services Elizabeth Beech Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England October 2015 elizabeth.beech@nhs.net Superbugs

More information

Role of the general physician in the management of sepsis and antibiotic stewardship

Role of the general physician in the management of sepsis and antibiotic stewardship Role of the general physician in the management of sepsis and antibiotic stewardship Prof Martin Wiselka Dept of Infection and Tropical Medicine University Hospitals of Leicester Sepsis and antibiotic

More information

Combination vs Monotherapy for Gram Negative Septic Shock

Combination vs Monotherapy for Gram Negative Septic Shock Combination vs Monotherapy for Gram Negative Septic Shock Critical Care Canada Forum November 8, 2018 Michael Klompas MD, MPH, FIDSA, FSHEA Professor, Harvard Medical School Hospital Epidemiologist, Brigham

More information

Does Early and Appropriate Antibiotic Administration Improve Mortality in Emergency Department Patients with Severe Sepsis or Septic Shock?

Does Early and Appropriate Antibiotic Administration Improve Mortality in Emergency Department Patients with Severe Sepsis or Septic Shock? References and Literature Grading Does Early and Appropriate Antibiotic Administration Improve Mortality in Emergency Department Patients with Severe Sepsis or Septic Shock? (9/6/2015) 1. Dellinger, R.P.,

More information

NUOVE IPOTESI e MODELLI di STEWARDSHIP

NUOVE IPOTESI e MODELLI di STEWARDSHIP Esperienze di successo di antimicrobial stewardship Bologna, 18 novembre 2014 NUOVE IPOTESI e MODELLI di STEWARDSHIP Pierluigi Viale Clinica di Malattie Infettive Policlinico S. Orsola Malpighi Interventions

More information

Antibiotic treatment in the ICU 1. ICU Fellowship Training Radboudumc

Antibiotic treatment in the ICU 1. ICU Fellowship Training Radboudumc Antibiotic treatment in the ICU 1 ICU Fellowship Training Radboudumc Main issues Delayed identification of microorganisms Impact of critical illness on Pk/Pd High prevalence of antibiotic resistant strains

More information

Why should we care about multi-resistant bacteria? Clinical impact and

Why should we care about multi-resistant bacteria? Clinical impact and Why should we care about multi-resistant bacteria? Clinical impact and public health implications Prof. Stephan Harbarth Infection Control Program Geneva, Switzerland and Ebola (in 2014/2015) Increased

More information

Guidance Notes on the Antimicrobial Companion Audit Tool for the Antimicrobial Prescribing Quality Indicators 2017/18

Guidance Notes on the Antimicrobial Companion Audit Tool for the Antimicrobial Prescribing Quality Indicators 2017/18 Guidance tes on the Antimicrobial Companion Audit Tool for the Antimicrobial Prescribing Quality Indicators 2017/18 Summary of the indicators The 2017/18 hospital antimicrobial prescribing quality indicators

More information

Burden of disease of antibiotic resistance The example of MRSA. Eva Melander Clinical Microbiology, Lund University Hospital

Burden of disease of antibiotic resistance The example of MRSA. Eva Melander Clinical Microbiology, Lund University Hospital Burden of disease of antibiotic resistance The example of MRSA Eva Melander Clinical Microbiology, Lund University Hospital Discovery of antibiotics Enormous medical gains Significantly reduced morbidity

More information

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of

More information

Evaluating the Role of MRSA Nasal Swabs

Evaluating the Role of MRSA Nasal Swabs Evaluating the Role of MRSA Nasal Swabs Josh Arnold, PharmD PGY1 Pharmacy Resident Pharmacy Grand Rounds February 28, 2017 2016 MFMER slide-1 Objectives Identify the pathophysiology of MRSA nasal colonization

More information

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial

More information

Appropriate antimicrobial therapy in HAP: What does this mean?

Appropriate antimicrobial therapy in HAP: What does this mean? Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,

More information

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM Mary Moore, MS CIC MT (ASCP) Infection Prevention Coordinator Great River Medical Center, West Burlington REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM ABOUT

More information

Methicillin-Resistant Staphylococcus aureus Nasal Swabs as a Tool in Antimicrobial Stewardship

Methicillin-Resistant Staphylococcus aureus Nasal Swabs as a Tool in Antimicrobial Stewardship Methicillin-Resistant Staphylococcus aureus Nasal Swabs as a Tool in Antimicrobial Stewardship Natalie R. Tucker, PharmD Antimicrobial Stewardship Pharmacist Tyson E. Dietrich, PharmD PGY2 Infectious Diseases

More information

Active Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.

Active Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply. Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted

More information

Antimicrobial therapy in critical care

Antimicrobial therapy in critical care Antimicrobial therapy in critical care KARLEE JOHNSTON LEAD PHARMACIST DIVISION OF CRITICAL CARE CANBERRA HOSPITAL AND HEALTH SERVICE Outline 1. Let s talk about sepsis 2. PK/PD considerations 3. Selecting

More information

Collecting and Interpreting Stewardship Data: Breakout Session

Collecting and Interpreting Stewardship Data: Breakout Session Collecting and Interpreting Stewardship Data: Breakout Session Michael S. Calderwood, MD, MPH Regional Hospital Epidemiologist, Dartmouth-Hitchcock Medical Center March 20, 2019 None Disclosures Outline

More information

Welcome! 10/26/2015 1

Welcome! 10/26/2015 1 Welcome! Audio for this event is available via ReadyTalk Internet Streaming. No telephone line is required. Computer speakers or headphones are necessary to listen to streaming audio. Limited dial-in lines

More information

The CARI Guidelines Caring for Australians with Renal Impairment. 8. Prophylactic antibiotics for insertion of peritoneal dialysis catheter

The CARI Guidelines Caring for Australians with Renal Impairment. 8. Prophylactic antibiotics for insertion of peritoneal dialysis catheter 8. Prophylactic antibiotics for insertion of peritoneal dialysis catheter Date written: February 2003 Final submission: May 2004 Guidelines (Include recommendations based on level I or II evidence) Antibiotic

More information

Le infezioni di cute e tessuti molli

Le infezioni di cute e tessuti molli Le infezioni di cute e tessuti molli SCELTE e STRATEGIE TERAPEUTICHE Pierluigi Viale Clinica di Malattie Infettive Policlinico S. Orsola Malpighi Treatment of complicated skin and skin structure infections

More information

10 Golden rules of Antibiotic Stewardship in ICU. Jeroen Schouten, MD PhD intensivist, Nijmegen (Neth) Istanbul, Oct 6th 2017

10 Golden rules of Antibiotic Stewardship in ICU. Jeroen Schouten, MD PhD intensivist, Nijmegen (Neth) Istanbul, Oct 6th 2017 10 Golden rules of Antibiotic Stewardship in ICU Jeroen Schouten, MD PhD intensivist, Nijmegen (Neth) Istanbul, Oct 6th 2017 10 golden rules of Antibiotic Stewardship in the ICU ID, Pharma & Micro advice

More information

MDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta

MDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta MDR Acinetobacter baumannii Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta 1 The Armageddon recipe Transmissible organism with prolonged environmental

More information

Surveillance of AMR in PHE: a multidisciplinary,

Surveillance of AMR in PHE: a multidisciplinary, Surveillance of AMR in PHE: a multidisciplinary, integrated approach Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright International

More information

Compliance with antibiotic treatment guidelines in managed care patients with communityacquired pneumonia in ambulatory settings

Compliance with antibiotic treatment guidelines in managed care patients with communityacquired pneumonia in ambulatory settings Compliance with antibiotic treatment guidelines in managed care patients with communityacquired pneumonia in ambulatory settings Jasmanda H. Wu, Ph.D., 1 David H. Howard, Ph.D., 2 John E. McGowan, Jr.,

More information

Jump Starting Antimicrobial Stewardship

Jump Starting Antimicrobial Stewardship Jump Starting Antimicrobial Stewardship Amanda C. Hansen, PharmD Pharmacy Operations Manager Carilion Roanoke Memorial Hospital Roanoke, Virginia March 16, 2011 Objectives Discuss guidelines for developing

More information

The Core Elements of Antibiotic Stewardship for Nursing Homes

The Core Elements of Antibiotic Stewardship for Nursing Homes The Core Elements of Antibiotic Stewardship for Nursing Homes APPENDIX B: Measures of Antibiotic Prescribing, Use and Outcomes National Center for Emerging and Zoonotic Infectious Diseases Division of

More information

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health

More information

Bacterial infections complicating cirrhosis

Bacterial infections complicating cirrhosis PHC www.aphc.info Bacterial infections complicating cirrhosis P. Angeli, Dept. of Medicine, Unit of Internal Medicine and Hepatology (), University of Padova (Italy) pangeli@unipd.it Agenda Epidemiology

More information

Original Date: 02/2010 Purpose: To maximize antibiotic stewardship for intraabdominal infection in the Precedes: 4/2013

Original Date: 02/2010 Purpose: To maximize antibiotic stewardship for intraabdominal infection in the Precedes: 4/2013 Division of Acute Care Surgery Clinical Practice Policies, Guidelines, and Algorithms: Antibiotic Therapy: Intra-Abdominal Infections Clinical Practice Algorithm Original Date: 02/2010 Purpose: To maximize

More information

Screening programmes for Hospital Acquired Infections

Screening programmes for Hospital Acquired Infections Screening programmes for Hospital Acquired Infections European Diagnostic Manufacturers Association In Vitro Diagnostics Making a real difference in health & life quality June 2007 HAI Facts Every year,

More information

POTENTIAL STRUCTURE INDICATORS FOR EVALUATING ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN EUROPEAN HOSPITALS

POTENTIAL STRUCTURE INDICATORS FOR EVALUATING ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN EUROPEAN HOSPITALS POTENTIAL STRUCTURE INDICATORS FOR EVALUATING ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN EUROPEAN HOSPITALS Dirk VOGELAERS Department of General Internal Medicine, Infectious Diseases and Psychosomatic Medicine

More information

Why we perform susceptibility testing

Why we perform susceptibility testing 22 nd June 2015 Why we perform susceptibility testing Robin A Howe Antimicrobial use in Primary Care Why do we perform AST? Clinical Clinical Prediction Prediction of of Efficacy Efficacy Why do we perform

More information

Optimize Durations of Antimicrobial Therapy

Optimize Durations of Antimicrobial Therapy Optimize Durations of Antimicrobial Therapy Evidence & Application Jill Cowper, Pharm.D. Division Infectious Diseases Pharmacist Parallon Supply Chain Solutions Richmond, VA P: 607 221 5101 jill.butterfield@parallon.com

More information

POINT PREVALENCE SURVEY A tool for antibiotic stewardship in hospitals. Koen Magerman Working group Hospital Medicine

POINT PREVALENCE SURVEY A tool for antibiotic stewardship in hospitals. Koen Magerman Working group Hospital Medicine POINT PREVALENCE SURVEY A tool for antibiotic stewardship in hospitals Koen Magerman Working group Hospital Medicine Background Strategic plan By means of a point prevalence survey and internal audits

More information

Antibacterials. Recent data on linezolid and daptomycin

Antibacterials. Recent data on linezolid and daptomycin Antibacterials Recent data on linezolid and daptomycin Patricia Muñoz, MD. Ph.D. (pmunoz@micro.hggm.es) Hospital General Universitario Gregorio Marañón Universidad Complutense de Madrid. 1 GESITRA Reasons

More information

Hot Topics in Antimicrobial Stewardship. Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital

Hot Topics in Antimicrobial Stewardship. Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital Hot Topics in Antimicrobial Stewardship Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital Antimicrobial Stewardship Goals Primary Goal Optimize clinical outcomes

More information

Study Protocol. Funding: German Center for Infection Research (TTU-HAARBI, Research Clinical Unit)

Study Protocol. Funding: German Center for Infection Research (TTU-HAARBI, Research Clinical Unit) Effectiveness of antibiotic stewardship interventions in reducing the rate of colonization and infections due to antibiotic resistant bacteria and Clostridium difficile in hospital patients a systematic

More information

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov

More information

Measurement of Antimicrobial Drug Use. Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist

Measurement of Antimicrobial Drug Use. Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist Measurement of Antimicrobial Drug Use Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist Defined Daily Dose Target Audience: Administrators and Epidemiologists Standardized definition

More information

Surgical prophylaxis for Gram +ve & Gram ve infection

Surgical prophylaxis for Gram +ve & Gram ve infection Surgical prophylaxis for Gram +ve & Gram ve infection Professor Mark Wilcox Clinical l Director of Microbiology & Pathology Leeds Teaching Hospitals & University of Leeds, UK Heath Protection Agency Surveillance

More information

Promoting Appropriate Antimicrobial Prescribing in Secondary Care

Promoting Appropriate Antimicrobial Prescribing in Secondary Care Promoting Appropriate Antimicrobial Prescribing in Secondary Care Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2015 Introduction Background ESPAUR

More information

Appropriate Antibiotic Administration in Critically Ill Patients with Pneumonia

Appropriate Antibiotic Administration in Critically Ill Patients with Pneumonia Research Paper Appropriate Antibiotic Administration in Critically Ill Patients with Pneumonia R. A. KHAN, M. M. BAKRY 1 AND F. ISLAHUDIN 1 * Hospital SgBuloh, Jalan Hospital, 47000 SgBuloh, Selangor,

More information

Core Elements of Antibiotic Stewardship for Nursing Homes

Core Elements of Antibiotic Stewardship for Nursing Homes Core Elements of Antibiotic Stewardship for Nursing Homes Nimalie D. Stone, MD, MS Medical Epidemiologist for LTC Division of Healthcare Quality Promotion Centers for Disease Control and Prevention Antimicrobial

More information

Konsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program

Konsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program Konsequenzen für Bevölkerung und Gesundheitssysteme Stephan Harbarth Infection Control Program University of Geneva Hospitals Outline Introduction What data sources are available? AMR-associated outcomes

More information

Quality indicators and outcomes in the devolved nations Scotland

Quality indicators and outcomes in the devolved nations Scotland Quality indicators and outcomes in the devolved nations Scotland Dr Jacqueline Sneddon, MRPharmS Project Lead, Scottish Antimicrobial Prescribing Group Federation of Infection Societies Conference Birmingham,

More information

Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.

Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S. Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S. Overview of benchmarking Antibiotic Use Scott Fridkin, MD, Senior Advisor for Antimicrobial

More information

Epidemiology of early-onset bloodstream infection and implications for treatment

Epidemiology of early-onset bloodstream infection and implications for treatment Epidemiology of early-onset bloodstream infection and implications for treatment Richard S. Johannes, MD, MS Marlborough, Massachusetts Health care-associated infections: For over 35 years, infections

More information

Pneumonia considerations Galia Rahav Infectious diseases unit Sheba medical center

Pneumonia considerations Galia Rahav Infectious diseases unit Sheba medical center Pneumonia considerations 2017 Galia Rahav Infectious diseases unit Sheba medical center Sir William Osler (1849 1919) "Father of modern medicine Pneumonia: The old man's friend The captain of the men of

More information

Rational management of community acquired infections

Rational management of community acquired infections Rational management of community acquired infections Dr Tanu Singhal MD, MSc Consultant Pediatrics and Infectious Disease Kokilaben Dhirubhai Ambani Hospital, Mumbai Why is rational management needed?

More information

Clinical Guideline. District Infectious Diseases Management. Go to Guideline. District Infectious Diseases Management CG 18_24

Clinical Guideline. District Infectious Diseases Management. Go to Guideline. District Infectious Diseases Management CG 18_24 Clinical Guideline District Infectious Diseases Management Sites where Clinical Guideline applies All facilities This Clinical Guideline applies to: 1. Adults Yes 2. Children up to 16 years Yes 3. Neonates

More information

Multi-drug resistant microorganisms

Multi-drug resistant microorganisms Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the

More information

Hospital Acquired Infections in the Era of Antimicrobial Resistance

Hospital Acquired Infections in the Era of Antimicrobial Resistance Hospital Acquired Infections in the Era of Antimicrobial Resistance Datuk Dr Christopher KC Lee Infectious Diseases Unit Department of Medicine Sungai Buloh Hospital Patient Story 23 Year old female admitted

More information

Mono- versus Bitherapy for Management of HAP/VAP in the ICU

Mono- versus Bitherapy for Management of HAP/VAP in the ICU Mono- versus Bitherapy for Management of HAP/VAP in the ICU Jean Chastre, www.reamedpitie.com Conflicts of interest: Consulting or Lecture fees: Nektar-Bayer, Pfizer, Brahms, Sanofi- Aventis, Janssen-Cilag,

More information

Reducing the Burden of Severe Sepsis and Infections in Indian ICUs

Reducing the Burden of Severe Sepsis and Infections in Indian ICUs Reducing the Burden of Severe Sepsis and Infections in Indian ICUs J.V. Divatia Professor & Head Department of Anaesthesia, Critical Care & Pain Tata Memorial Hospital Mumbai India Infections in the ICU

More information

Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial

Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial BRIEF REPORT Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial Rodger D. MacArthur, 1 Mark Miller, 2 Timothy Albertson, 3 Edward Panacek, 3

More information

La sepsi Il ruolo dell antibiotico terapia

La sepsi Il ruolo dell antibiotico terapia Congresso Nazionale AcEMC Fermo 11-12 Maggio 2017 La sepsi Il ruolo dell antibiotico terapia Michele Bartoletti Infectious Disease Unit - Sant Orsola Hospital, Bologna, Italy Disclosures: none Epidemiology

More information

ANTIMICROBIALS PRESCRIBING STRATEGY

ANTIMICROBIALS PRESCRIBING STRATEGY Directorate of Operations Clinical Support Services Diagnostic Services Pharmacy ANTIMICROBIALS PRESCRIBING STRATEGY Reference: DCM021 Version: 2.0 This version issued: 25/04/16 Result of last review:

More information

Ithas been estimated that one

Ithas been estimated that one Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department David F. Gaieski, MD; Jesse M. Pines,

More information

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012 Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton

More information

3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats

3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats Antibiotics --When Less is More Ralph Gonzales, MD, MSPH Associate Dean, Clinical Innovation School of Medicine VP, Clinical Innovation, UCSF Health Most Urgent Threats Serious Threats Multidrug-Resistant

More information

Antimicrobial stewardship in managing septic patients

Antimicrobial stewardship in managing septic patients Antimicrobial stewardship in managing septic patients November 11, 2017 Samuel L. Aitken, PharmD, BCPS (AQ-ID) Clinical Pharmacy Specialist, Infectious Diseases slaitken@mdanderson.org Conflict of interest

More information

Fighting MDR Pathogens in the ICU

Fighting MDR Pathogens in the ICU Fighting MDR Pathogens in the ICU Dr. Murat Akova Hacettepe University School of Medicine, Department of Infectious Diseases, Ankara, Turkey 1 50.000 deaths each year in US and Europe due to antimicrobial

More information

Antibiotic Stewardship in the Hospital Setting

Antibiotic Stewardship in the Hospital Setting Antibiotic Stewardship in the Hospital Setting G. Evans, MD FRCPC Medical Director, Infection Prevention & Control Kingston General Hospital & Hotel Dieu Hospital EOPIC September 26, 2012 Stewardship stew-ard-ship

More information

Susan Becker DNP, RN, CNS, CCRN, CCNS Marymount University, Arlington, VA

Susan Becker DNP, RN, CNS, CCRN, CCNS Marymount University, Arlington, VA Susan Becker DNP, RN, CNS, CCRN, CCNS Marymount University, Arlington, VA Disclosures Study and presentation has no commercial bias or interests No financial relationship with a commercial interest, products,

More information

NIH Public Access Author Manuscript Crit Care Med. Author manuscript; available in PMC 2012 September 1.

NIH Public Access Author Manuscript Crit Care Med. Author manuscript; available in PMC 2012 September 1. NIH Public Access Author Manuscript Published in final edited form as: Crit Care Med. 2011 September ; 39(9): 2066 2071. doi:10.1097/ccm.0b013e31821e87ab. Association Between Timing of Antibiotic Administration

More information

Gram negative bacteraemia

Gram negative bacteraemia Gram negative bacteraemia David Enoch Consultant Medical Microbiologist PHE Cambridge Cambridge University Hospitals NHS FT Overview Gram negative bacteraemia Changing epidemiology in England Epidemiology

More information

ANTIBIOTIC STEWARDSHIP

ANTIBIOTIC STEWARDSHIP ANTIBIOTIC STEWARDSHIP Adrie Bekker - Kenya 2018 Department of Pediatric and Child Health, Division of Neonatology University of Stellenbosch, Tygerberg Hospital DEFINITION OF ANTIMICROBIAL STEWARDSHIP

More information

Summary of unmet need guidance and statistical challenges

Summary of unmet need guidance and statistical challenges Summary of unmet need guidance and statistical challenges Daniel B. Rubin, PhD Statistical Reviewer Division of Biometrics IV Office of Biostatistics, CDER, FDA 1 Disclaimer This presentation reflects

More information

Taiwan Crit. Care Med.2009;10: %

Taiwan Crit. Care Med.2009;10: % 2008 30% 2008 2008 2004 813 386 07-346-8339 E-mail srwann@vghks.gov.tw 66 30% 2008 1 2008 2008 Intensive Care Med (2008)34:17-60 67 2 3 C activated protein C 4 5,6 65% JAMA 1995;273(2):117-23 Circulation,

More information

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University

More information

EVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK

EVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK EVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK EPIDEMIOLOGY AND BACKGROUND Every year, more than 2 million people in the United States acquire antibiotic-resistant

More information

Antimicrobial Stewardship Advisory Committee Meeting

Antimicrobial Stewardship Advisory Committee Meeting Antimicrobial Stewardship Advisory Committee Meeting August 25, 2016 3:00 PM-4:30 PM Washington State Dept of Health Room A42 1610 NE 150th St Shoreline, WA 98155 Call in: (571) 317-3116 Access Code: 211-449-029

More information

A Point Prevalence Survey of Antibiotic Prescriptions and Infection in Sanandaj Hospitals, Prospects for Antibiotic Stewardship

A Point Prevalence Survey of Antibiotic Prescriptions and Infection in Sanandaj Hospitals, Prospects for Antibiotic Stewardship A Point Prevalence Survey of Antibiotic Prescriptions and Infection in Sanandaj Hospitals, Prospects for Antibiotic Stewardship Jafar Soltani* Ann Versporten**, Behzad Mohsenpour*, Herman Goossen**, Soheila

More information

UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients

UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients Background/methods: UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients This guideline establishes evidence-based consensus standards for management

More information

Antibiotic resistance: the rise of the superbugs

Antibiotic resistance: the rise of the superbugs Antibiotic resistance: the rise of the superbugs Allen Cheng Associate Professor of Infectious Diseases Epidemiology, Alfred Health; Monash University About me Specialist in infectious diseases Head, Infection

More information

Meropenem for all? Midge Asogan ICU Fellow (also ID AT)

Meropenem for all? Midge Asogan ICU Fellow (also ID AT) Meropenem for all? Midge Asogan ICU Fellow (also ID AT) Infections Common reason for presentation to ICU Community acquired - vs nosocomial - new infection acquired within hospital environment Treatment

More information

Nosocomial Infections: What Are the Unmet Needs

Nosocomial Infections: What Are the Unmet Needs Nosocomial Infections: What Are the Unmet Needs Jean Chastre, MD Service de Réanimation Médicale Hôpital Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie, Paris 6, France www.reamedpitie.com

More information

Treatment of septic peritonitis

Treatment of septic peritonitis Vet Times The website for the veterinary profession https://www.vettimes.co.uk Treatment of septic peritonitis Author : Andrew Linklater Categories : Companion animal, Vets Date : November 2, 2016 Septic

More information

RESISTANCE, USE, INTERVENTIONS. Hugh Webb

RESISTANCE, USE, INTERVENTIONS. Hugh Webb RESISTANCE, USE, INTERVENTIONS Hugh Webb EU Initiatives: EARSS and ESAC. Antimicrobial Use and Resistance The Relationship. Bias and confounding in published studies. Mathematical modelling of resistance

More information

Antibiotic usage in nosocomial infections in hospitals. Dr. Birgit Ross Hospital Hygiene University Hospital Essen

Antibiotic usage in nosocomial infections in hospitals. Dr. Birgit Ross Hospital Hygiene University Hospital Essen Antibiotic usage in nosocomial infections in hospitals Dr. Birgit Ross Hospital Hygiene University Hospital Essen Infection control in healthcare settings - Isolation - Hand Hygiene - Environmental Hygiene

More information

Development of Drugs for HAP-VAP. Robert Fromtling, MD

Development of Drugs for HAP-VAP. Robert Fromtling, MD Development of Drugs for HAP-VAP Robert Fromtling, MD Hospital-Acquired & Ventilator- Associated Pneumonia (HAP-VAP) The EMA 2015 roadmap recognizes the need for new antibiotics New drugs for HAP-VAP are

More information

Lindsay E. Nicolle University of Manitoba Winnipeg, CANADA

Lindsay E. Nicolle University of Manitoba Winnipeg, CANADA Lindsay E. Nicolle University of Manitoba Winnipeg, CANADA Long Term Care Facilities: Spectrum low acuity assisted living mobile independent Not LTAC high acuity complete functional disability dialysis

More information

Advances in Antimicrobial Stewardship (AMS) at University Hospital Southampton

Advances in Antimicrobial Stewardship (AMS) at University Hospital Southampton Advances in Antimicrobial Stewardship (AMS) at University Hospital Southampton Dr Julian Sutton Consultant in Infectious Diseases & Medical Microbiology Federation of Infection Societies 1 st December,

More information

Antimicrobial Cycling. Donald E Low University of Toronto

Antimicrobial Cycling. Donald E Low University of Toronto Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and

More information

Antimicrobial Resistance and Papua New Guinea WHY is it important? HOW has the problem arisen? WHAT can we do?

Antimicrobial Resistance and Papua New Guinea WHY is it important? HOW has the problem arisen? WHAT can we do? Antimicrobial Resistance and Papua New Guinea WHY is it important? HOW has the problem arisen? WHAT can we do? John Ferguson, John Hunter Hospital, University of Newcastle, NSW, Australia Infectious Diseases

More information

M.L. Avent* 1,2, E.Waddell 1, K.Daveson 1 and K. Hajkowicz 1 1. Queensland Statewide Antimicrobial Stewardship 2. UQCCR, The University of Queensland

M.L. Avent* 1,2, E.Waddell 1, K.Daveson 1 and K. Hajkowicz 1 1. Queensland Statewide Antimicrobial Stewardship 2. UQCCR, The University of Queensland @MinyonAvent #ruralhealthconf M.L. Avent* 1,2, E.Waddell 1, K.Daveson 1 and K. Hajkowicz 1 1. Queensland Statewide Antimicrobial Stewardship 2. UQCCR, The University of Queensland Queensland State- Wide

More information

Assessment of empirical antibiotic therapy in a tertiary-care hospital: An observational descriptive study

Assessment of empirical antibiotic therapy in a tertiary-care hospital: An observational descriptive study IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 9 Ver. VI (September). 2016), PP 118-124 www.iosrjournals.org Assessment of empirical antibiotic

More information

Impact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital

Impact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital Impact of Antimicrobial Resistance on Human Health Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital AMR in Foodchain Conference, UCD, Dec 2014 Sir Patrick Dun s Hospital

More information

Antibiotic Guideline: Empirical Treatment of Bone and Joint Infection in Adults

Antibiotic Guideline: Empirical Treatment of Bone and Joint Infection in Adults Antibiotic Guideline: Empirical Treatment of Bone and Joint Infection in Adults Document type: Prescribing guideline Version: 5.0 Author (name and designation) Samim Patel, Antimicrobial Lead Pharmacist

More information

Health Informatics Centre, Division of Community Health Sciences, Dundee, UK

Health Informatics Centre, Division of Community Health Sciences, Dundee, UK REVIEW Appropriate vs. inappropriate antimicrobial therapy P. G. Davey and C. Marwick Health Informatics Centre, Division of Community Health Sciences, Dundee, UK ABSTRACT Inappropriate antimicrobial treatment

More information

MRSA in the United Kingdom status quo and future developments

MRSA in the United Kingdom status quo and future developments MRSA in the United Kingdom status quo and future developments Dietrich Mack Chair of Medical Microbiology and Infectious Diseases The School of Medicine - University of Wales Swansea P R I F Y S G O L

More information

Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report. July December 2013 Second and Third Quarters 2014

Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report. July December 2013 Second and Third Quarters 2014 H e a l i n g t h e B o d y E n r i c h i n g t h e M i n d N u r t u r i n g t h e S o u l Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report July December 213 Second and Third Quarters

More information

These recommendations were approved for use by the Pharmaceutical and Therapeutics Committee, RCWMCH on 1 February 2017.

These recommendations were approved for use by the Pharmaceutical and Therapeutics Committee, RCWMCH on 1 February 2017. Antibiotic regimens for suspected hospital-acquired infection (HAI) outside the Paediatric Intensive Care Unit at Red Cross War Memorial Children s Hospital (RCWMCH) Lead author: Brian Eley Contributing

More information

Antimicrobial Stewardship. October 2012

Antimicrobial Stewardship. October 2012 Antimicrobial Stewardship October 2012 Rising Antimicrobial Resistance Methicillin resistant staphylococcus aureus (MRSA) Vancomycin resistant enterococci (VRE) MDR and extremely drug resistant (XDR TB)

More information

Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities

Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities Introduction As the problem of antibiotic resistance continues to worsen in all healthcare setting, we

More information